EGFR and head and neck squamous cell carcinoma: Collectively, this provides evidence that that the class I HDAC inhibitor mocetinostat, the pan-HDAC inhibitor pracinostat, and the broad-spectrum HDAC–EGFR inhibitor CUDC-101 induced radiosensitisation in HNSCC cells through their impact in suppressing the efficiency of DSB repair.